Drug Eluting Balloon Market By Source, Product and Application - Global Industry Analysis & Forecast to 2025

Published On : February 2019 Pages : 180 Category: Pharma & Healthcare Report Code : HC022678

Drug Eluting Balloon Market By Source (Fruits & vegetables, Whole grains, Nuts & seeds) Product (Insoluble, Soluble) Application (Beverages, Animal feed, Food, Pharmaceuticals, Personal care & cosmetics) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The Drug Eluting Balloon Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Drug Eluting Balloons (DEB) are traditional semi-compliant angioplasty balloons covered with an enemy of proliferative medication which is discharged into vessel divider amid expansion of inflatable, for the most part at ostensible weights with a particular minimal inflation time. Drug eluting balloon plays an imperative part in current medicinal services, as it conveys prescription to vessel and anticipates neointimal hyperplasia.

Drivers and Restraints

Expanding rate of coronary artery diseases among individuals over the globe is a key factor anticipated to drive development of the worldwide market over the estimate time frame. As per the World Health Organization (WHO), around 17.9 Mn individuals pass on, consistently because of coronary illness over the globe. Moreover, rising makers inclination towards obtaining procedures all together build up an inventive products and extend their product portfolio is another factor expected to support development of the objective market over the gauge time frame.

Regional Insights

The market in North America is foreseen to prevailing in the worldwide medication eluting inflatable market as far as income over the conjecture time frame, attributable to expanding pervasiveness of cardiovascular ailments and stoutness crosswise over different nations in the locale over the estimate time frame.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Koninklijke Philips N.V.
  • Terumo Corporation
  • Biotronik, Inc.
  • Medtronic, Inc.
  • Boston Scientific Corporation
  • Braun Melsungen AG
  • Opto Circuits (India) Limited
  • Surmodics, Inc.

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Drug Eluting Balloon Market, By Product Type, Estimates and Forecast, 2014-2025 ($Million)

o    Peripheral Drug Eluting Balloon

o    Coronary Drug Eluting Balloon

o    Other

·         Drug Eluting Balloon Market, By End User, Estimates and Forecast, 2014-2025 ($Million)

o    CATH Laboratories

o    Hospitals

o    Ambulatory Surgery Centers

o    Others

·         Drug Eluting Balloon Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o    North America

§  North America Drug Eluting Balloon Market, By Country

o    U.S. Drug Eluting Balloon Market

o    Canada Drug Eluting Balloon Market

o    Mexico Drug Eluting Balloon Market

o    Europe

§  Europe Drug Eluting Balloon Market, By Country

o    Germany Drug Eluting Balloon Market

o    UK Drug Eluting Balloon Market

o    France Drug Eluting Balloon Market

o    Russia Drug Eluting Balloon Market

o    Italy Drug Eluting Balloon Market

o    Rest of Europe Drug Eluting Balloon Market

o    Asia-Pacific

§  Asia-Pacific Drug Eluting Balloon Market, By Country

o    China Drug Eluting Balloon Market

o    Japan Drug Eluting Balloon Market

o    South Korea Drug Eluting Balloon Market

o    India Drug Eluting Balloon Market

o    Southeast Asia Drug Eluting Balloon Market

o    Rest of Asia-Pacific Drug Eluting Balloon Market

o    South America

§  South America Drug Eluting Balloon Market

o    Brazil Drug Eluting Balloon Market

o    Argentina Drug Eluting Balloon Market

o    Columbia Drug Eluting Balloon Market

o    Rest of South America Drug Eluting Balloon Market

o    Middle East and Africa

§  Middle East and Africa Drug Eluting Balloon Market

o    Saudi Arabia Drug Eluting Balloon Market

o    UAE Drug Eluting Balloon Market

o    Egypt Drug Eluting Balloon Market

o    Nigeria Drug Eluting Balloon Market

o    South Africa Drug Eluting Balloon Market

o    Rest of MEA Drug Eluting Balloon Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Drug Eluting Balloon Market, By Product Type

5.1.     Introduction

5.2.     Global Drug Eluting Balloon Revenue and Market Share by Product Type (2014-2018)

5.2.1.  Global Drug Eluting Balloon Revenue and Revenue Share by Product Type (2014-2018)

5.3.     Peripheral Drug Eluting Balloon

5.3.1.  Global Peripheral Drug Eluting Balloon Revenue and Growth Rate (2014-2018)

5.4.     Coronary Drug Eluting Balloon

5.4.1.  Global Coronary Drug Eluting Balloon Revenue and Growth Rate (2014-2018)

5.5.     Other

5.5.1.  Global Other Revenue and Growth Rate (2014-2018)

6.       Drug Eluting Balloon Market, By End User

6.1.     Introduction

6.2.     Global Drug Eluting Balloon Revenue and Market Share by End User (2014-2018)

6.2.1.  Global Drug Eluting Balloon Revenue and Revenue Share by End User (2014-2018)

6.3.     CATH Laboratories

6.3.1.  Global CATH Laboratories Revenue and Growth Rate (2014-2018)

6.4.     Hospitals

6.4.1.  Global Hospitals Revenue and Growth Rate (2014-2018)

6.5.     Ambulatory Surgery Centers

6.5.1.  Global Ambulatory Surgery Centers Revenue and Growth Rate (2014-2018)

6.6.     Others

6.6.1.  Global Others Revenue and Growth Rate (2014-2018)

7.       Drug Eluting Balloon Market, By Region

7.1.     Introduction

7.2.     Global Drug Eluting Balloon Revenue and Market Share by Regions

7.2.1.  Global Drug Eluting Balloon Revenue by Regions (2014-2018)

7.3.     North America Drug Eluting Balloon by Countries

7.3.1.  North America Drug Eluting Balloon Revenue and Growth Rate (2014-2018)

7.3.2.  North America Drug Eluting Balloon Revenue (Million USD) by Countries (2014-2018)

7.3.3.  United States

7.3.3.1.  United States Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.4.  Canada

7.3.4.1.  Canada Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.5.  Mexico

7.3.5.1.  Mexico Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.     Europe Drug Eluting Balloon by Countries

7.4.1.  Europe Drug Eluting Balloon Revenue and Growth Rate (2014-2018)

7.4.2.  Europe Drug Eluting Balloon Revenue (Million USD) by Countries (2014-2018)

7.4.3.  Germany

7.4.3.1.  Germany Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.4.  France

7.4.4.1.  France Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.5.  UK

7.4.5.1.  UK Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  Russia

7.4.6.1.  Russia Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  Italy

7.4.7.1.  Italy Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.     Asia-Pacific Drug Eluting Balloon by Countries

7.5.1.  Asia-Pacific Drug Eluting Balloon Revenue and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Drug Eluting Balloon Revenue (Million USD) by Countries (2014-2018)

7.5.3.  China

7.5.3.1.  China Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.4.  Japan

7.5.4.1.  Japan Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5.  Korea

7.5.5.1.  Korea Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  India

7.5.6.1.  India Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.     South America Drug Eluting Balloon by Countries

7.6.1.  South America Drug Eluting Balloon Revenue and Growth Rate (2014-2018)

7.6.2.  South America Drug Eluting Balloon Revenue (Million USD) by Countries (2014-2018)

7.6.3.  Brazil

7.6.3.1.  Brazil Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.4.  Argentina

7.6.4.1.  Argentina Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.5.  Columbia

7.6.5.1.  Columbia Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.     Middle East and Africa Drug Eluting Balloon by Countries

7.7.1.  Middle East and Africa Drug Eluting Balloon Revenue and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Drug Eluting Balloon Revenue (Million USD) by Countries (2014-2018)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.5.  Egypt

7.7.5.1.  Egypt Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  South Africa

7.7.7.1.  South Africa Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Turkey

7.7.8.1.  Turkey Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.     Becton, Dickinson and Company

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Boston Scientific Corporation

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Surmodics, Inc.

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Medtronic, Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Terumo Corporation

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Cook Medical Incorporated

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Opto Circuits (India) Limited

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Braun Melsungen AG

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Biotronik, Inc.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Koninklijke Philips N.V.

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Global Drug Eluting Balloon Market Competition, by Manufacturer

9.1.     Global Drug Eluting Balloon Revenue and Market Share by Manufacturer (2016-2017)

9.2.     Global Drug Eluting Balloon Price By Region (2016-2017)

9.3.     Top 5 Drug Eluting Balloon Manufacturer Market Share

9.4.     Market Competition Trend

10.    Drug Eluting Balloon Market Forecast (2018-2025)

10.1. Global Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Drug Eluting Balloon Market Forecast by Regions (2018-2025)

10.2.1.      North America Drug Eluting Balloon Market Forecast (2018-2025)

10.2.1.1. United States Drug Eluting Balloon Market Forecast (2018-2025)

10.2.1.2. Canada Drug Eluting Balloon Market Forecast (2018-2025)

10.2.1.3. Mexico Drug Eluting Balloon Market Forecast (2018-2025)

10.2.2.      Europe Drug Eluting Balloon Market Forecast (2018-2025)

10.2.2.1. Germany Drug Eluting Balloon Market Forecast (2018-2025)

10.2.2.2. France Drug Eluting Balloon Market Forecast (2018-2025)

10.2.2.3. UK Drug Eluting Balloon Market Forecast (2018-2025)

10.2.2.4. Russia Drug Eluting Balloon Market Forecast (2018-2025)

10.2.2.5. Italy Drug Eluting Balloon Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Drug Eluting Balloon Market Forecast (2018-2025)

10.2.3.      Asia-Pacific Drug Eluting Balloon Market Forecast (2018-2025)

10.2.3.1. China Drug Eluting Balloon Market Forecast (2018-2025)

10.2.3.2. Japan Drug Eluting Balloon Market Forecast (2018-2025)

10.2.3.3. Korea Drug Eluting Balloon Market Forecast (2018-2025)

10.2.3.4. India Drug Eluting Balloon Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Drug Eluting Balloon Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Drug Eluting Balloon Market Forecast (2018-2025)

10.2.4.      South America Drug Eluting Balloon Market Forecast (2018-2025)

10.2.4.1. Brazil Drug Eluting Balloon Market Forecast (2018-2025)

10.2.4.2. Argentina Drug Eluting Balloon Market Forecast (2018-2025)

10.2.4.3. Columbia Drug Eluting Balloon Market Forecast (2018-2025)

10.2.4.4. Rest of South America Drug Eluting Balloon Market Forecast (2018-2025)

10.2.5.      Middle East and Africa Drug Eluting Balloon Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Drug Eluting Balloon Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Drug Eluting Balloon Market Forecast (2018-2025)

10.2.5.3. Egypt Drug Eluting Balloon Market Forecast (2018-2025)

10.2.5.4. Nigeria Drug Eluting Balloon Market Forecast (2018-2025)

10.2.5.5. South Africa Drug Eluting Balloon Market Forecast (2018-2025)

10.2.5.6. Turkey Drug Eluting Balloon Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Drug Eluting Balloon Market Forecast (2018-2025)

10.3. Drug Eluting Balloon Market Forecast by Product Type (2018-2025)

10.3.1.      Drug Eluting Balloon Forecast by Product Type (2018-2025)

10.3.2.      Drug Eluting Balloon Market Share Forecast by Product Type (2018-2025)

10.4. Drug Eluting Balloon Market Forecast by End User (2018-2025)

10.4.1.      Drug Eluting Balloon Forecast by End User (2018-2025)

10.4.2.      Drug Eluting Balloon Market Share Forecast by End User (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Drug Eluting Balloon Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Drug Eluting Balloon Revenue and Revenue Share by Product Type (2014-2018)
Figure Global Peripheral Drug Eluting Balloon Revenue and Growth Rate (2014-2018)
Figure Global Coronary Drug Eluting Balloon Revenue and Growth Rate (2014-2018)
Figure Global Other Revenue and Growth Rate (2014-2018)
Table Global Drug Eluting Balloon Revenue and Revenue Share by End User (2014-2018)
Figure Global CATH Laboratories Revenue and Growth Rate (2014-2018)
Figure Global Hospitals Revenue and Growth Rate (2014-2018)
Figure Global Ambulatory Surgery Centers Revenue and Growth Rate (2014-2018)
Figure Global Others Revenue and Growth Rate (2014-2018)
Table Global Drug Eluting Balloon Revenue by Regions (2014-2018)
Figure North America Drug Eluting Balloon Growth Rate (2014-2018)
Figure North America Drug Eluting Balloon Revenue and Growth Rate (2014-2018)
Figure North America Drug Eluting Balloon by Countries (2014-2018)
Figure North America Drug Eluting Balloon Revenue (Million USD) by Countries (2014-2018)
Figure United States Drug Eluting Balloon Growth Rate (2014-2018)
Figure United States Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Drug Eluting Balloon Growth Rate (2014-2018)
Figure Canada Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Drug Eluting Balloon Growth Rate (2014-2018)
Figure Mexico Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Drug Eluting Balloon Growth Rate (2014-2018)
Figure Europe Drug Eluting Balloon Revenue and Growth Rate (2014-2018)
Figure Europe Drug Eluting Balloon by Countries (2014-2018)
Figure Europe Drug Eluting Balloon Revenue (Million USD) by Countries (2014-2018)
Figure Germany Drug Eluting Balloon Growth Rate (2014-2018)
Figure Germany Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Drug Eluting Balloon Growth Rate (2014-2018)
Figure France Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Drug Eluting Balloon Growth Rate (2014-2018)
Figure UK Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Drug Eluting Balloon Growth Rate (2014-2018)
Figure Russia Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Drug Eluting Balloon Growth Rate (2014-2018)
Figure Italy Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Drug Eluting Balloon Growth Rate (2014-2018)
Figure Rest of Europe Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Drug Eluting Balloon Growth Rate (2014-2018)
Figure Asia-Pacific Drug Eluting Balloon Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Drug Eluting Balloon by Countries (2014-2018)
Figure Asia-Pacific Drug Eluting Balloon Revenue (Million USD) by Countries (2014-2018)
Figure China Drug Eluting Balloon Growth Rate (2014-2018)
Figure China Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Drug Eluting Balloon Growth Rate (2014-2018)
Figure Japan Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Drug Eluting Balloon Growth Rate (2014-2018)
Figure Korea Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Drug Eluting Balloon Growth Rate (2014-2018)
Figure India Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Drug Eluting Balloon Growth Rate (2014-2018)
Figure Southeast Asia Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Drug Eluting Balloon Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Drug Eluting Balloon Growth Rate (2014-2018)
Figure South America Drug Eluting Balloon Revenue and Growth Rate (2014-2018)
Figure South America Drug Eluting Balloon by Countries (2014-2018)
Figure South America Drug Eluting Balloon Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Drug Eluting Balloon Growth Rate (2014-2018)
Figure Brazil Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Drug Eluting Balloon Growth Rate (2014-2018)
Figure Argentina Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Drug Eluting Balloon Growth Rate (2014-2018)
Figure Columbia Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Drug Eluting Balloon Growth Rate (2014-2018)
Figure Rest of South America Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Drug Eluting Balloon Growth Rate (2014-2018)
Figure Middle East and Africa Drug Eluting Balloon Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Drug Eluting Balloon by Countries (2014-2018)
Figure Middle East and Africa Drug Eluting Balloon Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Drug Eluting Balloon Growth Rate (2014-2018)
Figure Saudi Arabia Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Drug Eluting Balloon Growth Rate (2014-2018)
Figure United Arab Emirates Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Drug Eluting Balloon Growth Rate (2014-2018)
Figure Egypt Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Drug Eluting Balloon Growth Rate (2014-2018)
Figure Nigeria Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Drug Eluting Balloon Growth Rate (2014-2018)
Figure South Africa Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Drug Eluting Balloon Growth Rate (2014-2018)
Figure Turkey Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Drug Eluting Balloon Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2014-2018)
Table Becton, Dickinson and Company Drug Eluting Balloon Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boston Scientific Corporation Drug Eluting Balloon Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Surmodics, Inc. Drug Eluting Balloon Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Medtronic, Inc. Drug Eluting Balloon Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Terumo Corporation Drug Eluting Balloon Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cook Medical Incorporated Drug Eluting Balloon Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Opto Circuits (India) Limited Drug Eluting Balloon Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Braun Melsungen AG Drug Eluting Balloon Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biotronik, Inc. Drug Eluting Balloon Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Koninklijke Philips N.V. Drug Eluting Balloon Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Drug Eluting Balloon Market Share by Manufacturer
Figure Global Drug Eluting Balloon Revenue and Market Share by Manufacturer
Table Global Drug Eluting Balloon Price by Region (2016-2017)
Figure Top 5 Drug Eluting Balloon Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Drug Eluting Balloon Revenue (Millions USD) and Growth Rate (2018-2025)
Table Drug Eluting Balloon Market Forecast by Regions (2018-2025)
Figure North America Drug Eluting Balloon Market Forecast (2018-2025)
Figure United States Drug Eluting Balloon Market Forecast (2018-2025)
Figure Canada Drug Eluting Balloon Market Forecast (2018-2025)
Figure Mexico Drug Eluting Balloon Market Forecast (2018-2025)
Figure Europe Drug Eluting Balloon Market Forecast (2018-2025)
Figure Germany Drug Eluting Balloon Market Forecast (2018-2025)
Figure France Drug Eluting Balloon Market Forecast (2018-2025)
Figure UK Drug Eluting Balloon Market Forecast (2018-2025)
Figure Russia Drug Eluting Balloon Market Forecast (2018-2025)
Figure Italy Drug Eluting Balloon Market Forecast (2018-2025)
Figure Rest of Europe Drug Eluting Balloon Market Forecast (2018-2025)
Figure Asia-Pacific Drug Eluting Balloon Market Forecast (2018-2025)
Figure China Drug Eluting Balloon Market Forecast (2018-2025)
Figure Japan Drug Eluting Balloon Market Forecast (2018-2025)
Figure Korea Drug Eluting Balloon Market Forecast (2018-2025)
Figure India Drug Eluting Balloon Market Forecast (2018-2025)
Figure Southeast Asia Drug Eluting Balloon Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Drug Eluting Balloon Market Forecast (2018-2025)
Figure South America Drug Eluting Balloon Market Forecast (2018-2025)
Figure Brazil Drug Eluting Balloon Market Forecast (2018-2025)
Figure Argentina Drug Eluting Balloon Market Forecast (2018-2025)
Figure Columbia Drug Eluting Balloon Market Forecast (2018-2025)
Figure Rest of South America Drug Eluting Balloon Market Forecast (2018-2025)
Figure Middle East and Africa Drug Eluting Balloon Market Forecast (2018-2025)
Figure Saudi Arabia Drug Eluting Balloon Market Forecast (2018-2025)
Figure United Arab Emirates Drug Eluting Balloon Market Forecast (2018-2025)
Figure Egypt Drug Eluting Balloon Market Forecast (2018-2025)
Figure Nigeria Drug Eluting Balloon Market Forecast (2018-2025)
Figure South Africa Drug Eluting Balloon Market Forecast (2018-2025)
Figure Turkey Drug Eluting Balloon Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Drug Eluting Balloon Market Forecast (2018-2025)
Figure Global Drug Eluting Balloon Forecast by Product Type (2018-2025)
Figure Global Drug Eluting Balloon Market Share Forecast by Product Type (2018-2025)
Figure Global Drug Eluting Balloon Forecast by Product Type (2018-2025)
Figure Global Drug Eluting Balloon Forecast by End User (2018-2025)
Figure Global Drug Eluting Balloon Market Share Forecast by End User (2018-2025)
Figure Global Drug Eluting Balloon Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*